Quick Answer
Adaptive Biotechnologies Corp reported Net Income of -$59.50 million for fiscal year 2025.
Adaptive Biotechnologies Corp Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$59.50M | +62.7% |
| 2024 | -$159.49M | +29.2% |
| 2023 | -$225.25M | -12.5% |
| 2022 | -$200.19M | +3.4% |
| 2021 | -$207.28M | -41.8% |
| 2020 | -$146.23M | -113.1% |
| 2019 | -$68.61M | -47.7% |
| 2018 | -$46.45M | -8.4% |
| 2017 | -$42.83M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.55M | +129.8% | +137.3% |
| June 30, 2025 | -$25.61M | +44.6% | +14.2% |
| March 31, 2025 | -$29.85M | +37.2% | +6.9% |
| September 30, 2024 | -$32.07M | +36.2% | +30.6% |
| June 30, 2024 | -$46.22M | +3.3% | +2.7% |
| March 31, 2024 | -$47.51M | +17.7% | +5.6% |
| September 30, 2023 | -$50.30M | -11.1% | -5.2% |
| June 30, 2023 | -$47.81M | +8.1% | +17.1% |
- Adaptive Biotechnologies Corp showed an increase of +62.7% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, Adaptive Biotechnologies Corp’s net income has declined by 38.9% (from -$42.83 million to -$59.50 million).
- The most recent figure is from Adaptive Biotechnologies Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: